JG
NTUS

Jefferies Group’s Natus Medical Inc NTUS Stock Holding History

Jefferies Group’s Portfolio NTUS Stock Details NTUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-10,147
Closed -$335K – 2830
2019
Q4 		$335K Buy
+10,147
New +$325K ﹤0.01% 2024
2019
Q1 		– Sell
-11,759
Closed -$400K – 2744
2018
Q4 		$400K Buy
+11,759
New +$382K ﹤0.01% 1551
2018
Q1 		– Sell
-5,584
Closed -$213K – 2854
2017
Q4 		$213K Sell
5,584
-8,139
-59% -$325K ﹤0.01% 2182
2017
Q3 		$515K Buy
13,723
+2,514
+22% +$88.7K ﹤0.01% 1616
2017
Q2 		$418K Buy
+11,209
New +$405K ﹤0.01% 1689
2015
Q3 		– Sell
-4,594
Closed -$196K – 3269
2015
Q2 		$196K Sell
4,594
-511
-10% -$20.4K ﹤0.01% 1968
2015
Q1 		$201K Buy
+5,105
New +$188K ﹤0.01% 1767
2014
Q3 		– Sell
-8,800
Closed -$221K – 2543
2014
Q2 		$221K Buy
+8,800
New +$218K ﹤0.01% 1704

Other funds holding NTUS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
SAM
Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
CRM
Cramer Rosenthal McGlynn Stamford, Connecticut $1.36B AUM 31.72% 1-Year Est. Return

Jefferies Group's NTUS Position: Q1 2020 in Review

Jefferies Group sold out of Natus Medical Inc (NTUS) in Q1 2020, closing a stake of 10,147 shares — an estimated $335K sold.

Jefferies Group first reported a position in NTUS in Q2 2014 and held it in 8 quarters. The position peaked at $515K in Q3 2017. 166 funds tracked by Wall St. Rank hold NTUS as of Q1 2020.

  • Jefferies Group reported no remaining Natus Medical Inc position as of Q1 2020 after selling out during the quarter.
  • Jefferies Group sold 10,147 Natus Medical Inc shares in Q1 2020, an estimated $335K.
  • Jefferies Group first reported a position in Natus Medical Inc in Q2 2014 and held it in 8 quarters.
  • Jefferies Group's Natus Medical Inc position peaked at $515K in Q3 2017.
  • 166 funds tracked by Wall St. Rank held Natus Medical Inc as of Q1 2020.

Based on Jefferies Group's 13F filing for Q1 2020, filed 15 May 2020.